Torcetrapib is the anti cholesterol drug that Pfizer took out of Phase III clinical trials in December 2006.
-
Pfizer is to increase the number of biologics in its pipeline and is... -
CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) targets T cells; an antibody to... -
Pfizer has been in the Cork area since 1969 and has a number of plants,... -
Torcetrapib is the anti cholesterol drug that Pfizer took out of Phase III...
Twitter